Skip to content
The Policy VaultThe Policy Vault

Vivjoa (oteseconazole capsules - Mycovia)Cigna

Recurrent vulvovaginal candidiasis (RVVC)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has had at least three episodes of vulvovaginal candidiasis in a 12-month period (a patient with two or more previous episodes of vulvovaginal candidiasis in the previous 12 months would meet this requirement)
  • Patient is NOT of reproductive potential (defined as a biological female who is postmenopausal or has another reason for permanent infertility such as tubal ligation, hysterectomy, or salpingo-oophorectomy)
  • Patient is NOT pregnant
  • Patient is NOT breastfeeding

Approval duration

4 months